These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5097361)

  • 41. [Comparative studies of the efficacy of amezinium and etilefrin in aged patients with hypotonic blood circulation regulatory disorders].
    Jansen W
    Med Welt; 1982 Oct; 32(40):1491-6. PubMed ID: 6125868
    [No Abstract]   [Full Text] [Related]  

  • 42. [Malignant syndromes and sudden death, during treatments with simple and delayed-action neuroleptic drugs].
    Bourgeois M; Tignol J; Henry P
    Ann Med Psychol (Paris); 1971 Dec; 2(5):729-46. PubMed ID: 5144687
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experimental and clinical results of a new blood pressure increasing substance (2,5-dimethoxyphenyl-2-glycinamidoethanol-1-hydrochloride)].
    Paumgartner G; Pokorny D; Grabner G
    Wien Klin Wochenschr; 1970 Jun; 82(26):490-4. PubMed ID: 5520165
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the objective determination of autonomic disorders and results of their management].
    Klein K; Siedek H
    Munch Med Wochenschr; 1966 May; 108(19):1059-63. PubMed ID: 6014763
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension.
    Dorph S; Binder C
    Acta Med Scand; 1969 May; 185(5):443-8. PubMed ID: 5808645
    [No Abstract]   [Full Text] [Related]  

  • 46. [A study of 2-dimethylaminoethanol (DMAE) in various forms of psychoneurosis].
    Pugliese L; Papeschi R
    Riv Neurobiol; 1966; 12(2):251-63. PubMed ID: 5335605
    [No Abstract]   [Full Text] [Related]  

  • 47. [Is a single dose of dihydroergotamine per day sufficient?].
    Jansen W; Enghofer E; Seibel K
    MMW Munch Med Wochenschr; 1983 Jun; 125(23):498-502. PubMed ID: 6410213
    [No Abstract]   [Full Text] [Related]  

  • 48. [Adyston delayed-action capsules. Treatment of hypotonic blood circulation disorders with Adyston delayed-action capsules. Results of a field study].
    Schreiber H; Ozkaynak I
    ZFA (Stuttgart); 1980 Oct; 56(28):1851-8. PubMed ID: 7467751
    [No Abstract]   [Full Text] [Related]  

  • 49. Symptomatic orthostatic essential hypotension Part 2.
    Raij KA
    Br J Clin Pract; 1983 Sep; 37(9):289-94. PubMed ID: 6354235
    [No Abstract]   [Full Text] [Related]  

  • 50. [Efficacy of midodrin in orthostatic circulatory disorders. Results of a 2d multicentric field study of 942 patients].
    Lossnitzer K; Letzel H
    Med Welt; 1983 Oct; 34(42):1190-3. PubMed ID: 6196595
    [No Abstract]   [Full Text] [Related]  

  • 51. [Dihydroergotamine in the prevention and treatment of post-operative orthostatic hypotension in gynecology and obstetrics].
    Gelle P; Crepin G; Theillier L
    Lille Med; 1971 Apr; 16():S 2:631-7. PubMed ID: 5162099
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical study of the orthostatic syndrome in the puerperium].
    Suppi G; Pizzolon G
    Riv Ostet Ginecol; 1969 Jul; 24(7):227-32. PubMed ID: 5393493
    [No Abstract]   [Full Text] [Related]  

  • 53. [Results of a controlled clinical study on a new retard antihypotensive agent with reference to Schellong's test].
    Hunold W
    Z Allgemeinmed; 1975 Mar; 51(8):383-5. PubMed ID: 1094756
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical evaluation of the delayed-action isoxsuprin on peripheral circulation].
    Ambrosioni E; Perri G; Pascucci E; Fici F
    G Clin Med; 1971 Jul; 52(7):552-63. PubMed ID: 5152348
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of two new sulfonic acid esters of aminoglycols on chronic myelogenous leukemia.
    Hirano M; Miura M; Kakizawa H; Morita A; Uetani T
    Cancer Chemother Rep; 1972 Feb; 56(1):47-52. PubMed ID: 4503637
    [No Abstract]   [Full Text] [Related]  

  • 56. [Therapy of orthostatic circulatory lability. Oral dihydroergotamine in various galenic preparations in comparative studies on orthostasis reactions].
    Kayser-Petersen E
    Fortschr Med; 1978 Jul; 96(25):1339-42. PubMed ID: 669523
    [No Abstract]   [Full Text] [Related]  

  • 57. [Dihydroergotamine in orthostatic dysregulation].
    Heck J
    Med Klin; 1971 Apr; 66(16):601-4. PubMed ID: 5552926
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical effect of local anesthetic agent, hexylcaine].
    Masaki K; Hattori H; Shimada T; Ota M; Kawagoe F
    Shikwa Gakuho; 1970 Aug; 70(8):1062-5. PubMed ID: 5271803
    [No Abstract]   [Full Text] [Related]  

  • 59. [Phenylephrine correction of hypotension caused by sedative neuroleptics].
    Stefanini F; Lambert PA
    Lyon Med; 1970 Nov; 224(36):571-6. PubMed ID: 5504795
    [No Abstract]   [Full Text] [Related]  

  • 60. Octreotide for orthostatic hypotension.
    Lamarre-Cliche M; Cusson J
    Can J Clin Pharmacol; 1999; 6(4):213-5. PubMed ID: 10601755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.